Naloxone topical - Elorac

Drug Profile

Naloxone topical - Elorac

Alternative Names: E-0316; Naloxone hydrochloride dehydrate lotion

Latest Information Update: 03 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Elorac
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists; Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pruritus
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pruritus

Most Recent Events

  • 03 Mar 2017 Phase-III development is ongoing in USA (Topical)
  • 01 Jan 2017 Elorac initiates enrolment in a phase III trial for Pruritus in USA (Topical) (NCT02811783)
  • 22 Jun 2016 Elorac plans a phase III trial for Pruritus in USA (Topical) (NCT02811783)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top